Samlyn Capital, LLC Vera Therapeutics, Inc. Transaction History
Samlyn Capital, LLC
- $6.21 Billion
- Q4 2024
A detailed history of Samlyn Capital, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Samlyn Capital, LLC holds 1,662,220 shares of VERA stock, worth $47.5 Million. This represents 1.13% of its overall portfolio holdings.
Number of Shares
1,662,220
Previous 1,359,227
22.29%
Holding current value
$47.5 Million
Previous $60.1 Million
17.03%
% of portfolio
1.13%
Previous 0.97%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$160 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$125 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$95.4 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$84.6 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$84.3 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $773M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...